Probing the Förster Resonance Energy Transfer Dynamics in Colloidal Donor-Acceptor Quantum Dots Assemblies.

In this article, we report the synthesis of graphene quantum dots (GQDs) by hydrothermal method and surface modified CdS quantum dots (QDs) via the colloidal method and the fabrication of their dyad. The CdS QDs functionalized by mercaptoacetic acid (MAA) attach to the GQDs via electrostatic interactions. Spectral overlapping between the emission spectrum of GQDs and the absorption spectrum of CdS QDs allows efficient Förster resonance energy transfer (FRET) from GQDs to the CdS QDs in the GQDs-CdS QDs dyads. The magnitude of FRET efficiency (E) and the rate of energy transfer (kE) assessed by the photoluminescence (PL) decay kinetics are ~61.84% and ⁓3.8 × 108 s- 1, respectively. These high values of FRET efficiency and energy transfer rate can be assigned to the existence of strong electrostatic interactions between GQDs and CdS QDs, which arise due to the presence of polar functionalities on the surface of both GQDs and CdS QDs. The understanding of energy transfer in the luminescent donor-acceptor FRET system is of significant importance and the practical implications of such FRET systems could overall improve the efficiency of photovoltaics, sensing, imaging and optoelectronic devices.

Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated With a Defect in IKAROS.

OBJECTIVE: Mutations in IKZF1, which encodes Ikaros family zinc finger 1 (IKAROS) transcription factor, are associated with recurrent infections, cytopenia, autoimmune diseases, and hematologic malignancies. Diverse clinical phenotypes resulting from IKZF1 mutations include pulmonary fungal infections, cytopenia, autoimmune hemolytic anemia (AIHA), and malignancies. In this study, we aimed to assess the DNA-binding ability and pericentromeric (PC) localization of a variant of IKZF discovered in a patient. MATERIALS AND METHODS: DNA-binding ability of a pathogenic IKZF variant was tested using electrophoretic mobility shift assay and PC localization of the variant was assessed by immunofluorescent microscopy in NIH3T3 cells. RESULTS: Clinical features of a 3-month-old male infant who underwent hematopoietic stem cell transplantation because of an IKZF1 mutation-associated common variable immunodeficiency, AIHA, and pancytopenia are described. DNA studies revealed a heterozygous missense variant (IKZF1 NM_006060 c.427C>T; p.R143W). Cotransfection studies revealed that mutant R143W has a partial dominant-negative effect over PC targeting and DNA binding. CONCLUSIONS: IKZF1 mutation must be kept in mind if neonatal AIHA, common variable immunodeficiency, and pancytopenia are observed.

Effect of surface ligands on the photoinduced electron transfer rate and efficiency in ZnO quantum dots and graphene oxide assemblies.

Apart from biocompatibility, ZnO quantum dots (QDs) are considered to be an efficient luminescence material due to their low cost and high redox potential. Here, we report the synthesis of ZnO QDs by using five different functionalizing ligands like mercaptoacetic acid (MAA), 3-mercaptopropionic acid (MPA), octadecene (ODE), ethylene glycol (EG), and oleyl amine (OLA) and fabricate their assemblies with graphene oxide (GO). We investigate the role of functionalizing ligands as a surface modifier of ZnO QDs for their attachment to GO. The steady-state photoluminescence (SSPL) and time-resolved photoluminescence (TRPL) analyses demonstrate the photoluminescence (PL) quenching of ZnO QDs in ZnO QDs-GO assembly. The highest reduction in PL intensity is observed with ZnO QDs-GO assembly with EG as a surface functionalizing ligand. Cyclic voltammetry (CV) analysis confirms the feasibility of charge transfer from ZnO QDs to the GO. The maximum (79.43%) charge transfer efficiency (ECT ) is observed in the case of ZnO-MAA-GO as compared to other assemblies. This means the thiol group-containing ligands facilitate charge transfer as compared to hydroxyl and amine group ligands. This leads to the conclusion that charge transfer in ZnO QDs-GO assemblies depends strongly on the nature of surface ligands.

Hepatopathies in children and adolescents with type 1 diabetes.

Background Diabetes and hepatosteatosis are dramatically increasing in childhood. Non-alcoholic fatty liver disease (NAFLD) is defined as a common disorder in adulthood, especially with type-2 diabetes and metabolic syndrome, while very few studies are available on liver health in children with type-1 diabetes. Patients and methods One hundred and ten (52 males and 58 females) patients with type-1 diabetes aged between 8 and 18 years were examined. The lipid profile, liver enzymes and hepatobiliary ultrasound findings of patients were investigated in terms of hepatopathies. Patients diagnosed with fatty liver were evaluated by pediatric gastroenterology specialists for the differential diagnosis and exclusion of other etiologies. The relationships between hepatopathy and age, pubertal status, the duration of diabetes and glycemic control were evaluated. Results Hepatopathy was found in 17 (15.5%) patients. The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were normal and did not correlate with the ultrasonography (USG) findings. Hyperechogenicity detected by USG, whether it is true fat or glycogen hepatopathy, was found to be associated with "poor glycemic control" independently of age, puberty status and the duration of diabetes. Conclusions This study contributes to the literature in terms of the relationship between liver health and glycemic control in pediatric type-1 diabetes. Hepatopathies were releated with poor glycemic control independently of the duration of diabetes. This suggested that liver disorders should be considered as one of the subacute complications of diabetes. It was concluded that routine screening for comorbidities and complications in type-1 diabetes should also include hepatobiliary USG, as liver enzymes alone are inadequate for detecting hepatopathies.